|
RNF216 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.416260E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.347900E-02 |
| Normal-vs-Stage2 |
8.807800E-01 |
| Normal-vs-Stage3 |
3.459000E-03 |
| Normal-vs-Stage4 |
9.791700E-04 |
| Stage1-vs-Stage2 |
6.434100E-02 |
| Stage1-vs-Stage3 |
2.012200E-01 |
| Stage1-vs-Stage4 |
1.284990E-01 |
| Stage2-vs-Stage3 |
1.853630E-02 |
| Stage2-vs-Stage4 |
1.395990E-02 |
| Stage3-vs-Stage4 |
6.370600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.579900E-03 |
| Normal-vs-AfricanAmerican |
4.925000E-01 |
| Normal-vs-Asian |
1.075770E-01 |
| Caucasian-vs-AfricanAmerican |
2.645400E-01 |
| Caucasian-vs-Asian |
5.398000E-01 |
| AfricanAmerican-vs-Asian |
5.481400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.179600E-02 |
| Normal-vs-Female |
2.131600E-02 |
| Male-vs-Female |
6.556800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.732000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.148300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.800480E-02 |
| Normal-vs-Age(81-100Yrs) |
8.916400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.152000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.699000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.171800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.020600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.185400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.792400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.217490E-03 |
| Classical-VS-Follicular |
2.132600E-01 |
| Classical-VS-Other |
1.205400E-01 |
| Classical-VS-Normal |
9.613800E-02 |
| Tall-VS-Follicular |
3.016200E-02 |
| Tall-VS-Other |
9.148000E-01 |
| Tall-VS-Normal |
3.83649999999847E-05 |
| Follicular-VS-Other |
3.945000E-01 |
| Follicular-VS-Normal |
2.009900E-02 |
| Other-VS-Normal |
2.538300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.375900E-02 |
| Normal-vs-N1 |
1.208310E-04 |
| N0-vs-N1 |
1.963740E-02 |
|
|
